Microbiome-Based Therapeutics: The Future of Chronic Disease Management

Authors

  • Asim Kumar Basak Department of Allied Health Sciences, Brainware University, Barasat, Kolkata, India.
  • Debayan Chakraborty Department of Allied Health Sciences, Brainware University, Barasat, Kolkata, India.

DOI:

https://doi.org/10.9734/bpi/dhrd/v4/4163

Keywords:

Gut microbiome, chronic diseases, metabolic disorders, fecal microbiota transplantation, bacteriocins

Abstract

The gut microbiome, a complex community of microorganisms residing in the human gastrointestinal tract, plays an integral role in maintaining host health. Comprising trillions of bacteria, viruses, fungi, and other microorganisms, the gut microbiome has become a focal point in understanding human physiology, immunity, and disease. Recent advances in microbiome research have illuminated its therapeutic potential in diverse health conditions, ranging from gastrointestinal disorders to systemic diseases like diabetes and depression. This review explores the therapeutic role of the gut microbiome, emphasizing its impact on health, mechanisms of action, and emerging therapeutic applications.

Published

2025-02-05

How to Cite

Asim Kumar Basak, & Debayan Chakraborty. (2025). Microbiome-Based Therapeutics: The Future of Chronic Disease Management. Disease and Health: Research Developments Vol. 4, 89–106. https://doi.org/10.9734/bpi/dhrd/v4/4163